Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression.
about
20(S)-protopanaxadiol inhibition of progression and growth of castration-resistant prostate cancer.Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells.Methylselenocysteine preventing castration-resistant progression of prostate cancerThe loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients.L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer.
P2860
Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Carbidopa abrogates L-dopa dec ...... ys prostate tumor progression.
@en
Carbidopa abrogates L-dopa dec ...... ys prostate tumor progression.
@nl
type
label
Carbidopa abrogates L-dopa dec ...... ys prostate tumor progression.
@en
Carbidopa abrogates L-dopa dec ...... ys prostate tumor progression.
@nl
prefLabel
Carbidopa abrogates L-dopa dec ...... ys prostate tumor progression.
@en
Carbidopa abrogates L-dopa dec ...... ys prostate tumor progression.
@nl
P2093
P2860
P356
P1476
Carbidopa abrogates L-dopa dec ...... ys prostate tumor progression.
@en
P2093
Fariba Ghaidi
Helen Cheng
Ladan Fazli
Latif A Wafa
Martin E Gleave
Michael E Cox
Nathan Plaa
Paul S Rennie
Takahiro Fukumoto
P2860
P304
P356
10.1002/IJC.26287
P577
2011-09-14T00:00:00Z